Medical cannabis laws and medical and non-medical prescription stimulant use among a nationally representative sample of US Adults: Examining the role of sexual identity and gender.
Medical cannabis laws and medical and non-medical prescription stimulant use among a nationally representative sample of US Adults: Examining the role of sexual identity and gender.
复制标题
DOI：
10.1016/j.drugpo.2020.102861
复制
发表时间：
2020-10
期刊：
影响因子：
--
通讯作者：
Martins SS
中科院分区：
文献类型：
--
作者：
Philbin MM;Mauro PM;Greene ER;LaBossier NJ;Giovenco DP;Martins SS
医用大麻法 (MML) 可能会影响大麻和阿片类药物的使用，但 MML 与处方兴奋剂等其他药物之间的关系仍未得到检验。由于女同性恋、男同性恋和双性恋 (LGB) 个体报告的处方兴奋剂使用水平高于异性恋者，因此我们按性别认同和性别探讨了 MML 与过去一年医疗和非医疗兴奋剂使用之间的关系。我们汇总了 2015-2017 年全国成人药物使用和健康调查数据 (n=126 463)，并使用调查加权多项逻辑回归来估计过去一年 (a) 医疗处方兴奋剂使用、(b) 非医疗处方兴奋剂使用和 (c) 非医疗与医疗兴奋剂使用的几率。我们按性别进行分层，根据社会人口特征进行调整，并测试了 MML 州居住与性别认同之间的相互作用。双性恋男性的医疗兴奋剂使用率较高（6.4% vs 4.1%；aROR=1.93[1.29-2.88]），非医疗兴奋剂使用率较高，分别为 6.6% vs 2.4%； aROR=2.23[1.44-3.44]）高于异性恋男性。与异性恋女性相比，双性恋女性的非医疗兴奋剂使用率更高（6.8% 比 1.6%；aROR=1.54[1.23-2.93]。MML 州的女性 (aROR=0.70[0.62-0.78]) 和男性 (aROR=0.74[0.66-0.82]) 异性恋者使用医疗兴奋剂的几率低于 MML 州的异性恋者。 MML 州的双性恋男性使用医疗 (aROR=0.36[0.21-0.61]) 和非医疗 (aROR=0.48[0.29-0.81]) 的几率低于非 MML 州的双性恋男性的非医疗使用 (aROR=0.57[0.40-0.81]) 的类似模式。对于大多数 LGB 亚群体，非 MML 州的处方兴奋剂使用率较高，这可能会对兴奋剂使用产生不同的影响，主要是对双性恋男性和女性而言，制定 MML 的州应考虑对大麻以外的药物的潜在影响，尤其是对 LGB 人群。
Medical marijuana laws (MMLs) can impact marijuana and opioid use, but the relationship between MMLs and other drugs, such as prescription stimulants, remains unexamined. Because lesbian, gay and bisexual (LGB) individuals report higher levels of prescription stimulant use than heterosexuals, we explored the relationship between MMLs and past-year medical and non-medical stimulant use by sexual identity and gender. We pooled 2015-2017 National Survey on Drug Use and Health data for adults (n=126 463), and used survey-weighted multinomial logistic regression to estimate odds of past-year (a) medical prescription stimulant use, (b) non-medical prescription stimulant use and (c) non-medical versus medical stimulant use. We stratified by gender, adjusted for sociodemographic characteristics, and tested the interaction between MML state residence and sexual identity. Bisexual men had higher medical (6.4% versus 4.1%; aROR=1.93[1.29-2.88]) and nonmedical stimulant use 6.6% versus 2.4%; aROR=2.23[1.44-3.44]) than heterosexual men. Bisexual women had higher non-medical stimulant use (6.8% versus 1.6%; aROR=1.54[1.23-2.93] than heterosexual women. Female (aROR=0.70[0.62-0.78]) and male (aROR=0.74[0.66-0.82]) heterosexuals in MML states had lower odds of medical stimulant use than in non-MML states. Bisexual men in MML states had lower odds of medical (aROR=0.36[0.21-0.61]) and non-medical stimulant use (aROR=0.48[0.29-0.81]) than bisexual men in non-MML states. Similar patterns emerged for bisexual women’s non-medical use (aROR=0.57[0.40-0.81]). Prescription stimulant use was higher in non-MML states for most LGB subgroups. MMLs may differentially impact stimulant use, primarily for bisexual men and women. States enacting MMLs should consider potential impacts on drugs other than marijuana, especially among LGB populations.
登录
查看更多内容
影响因子：
4.4
作者：
Corliss, Heather L.;Rosario, Margaret;Wypij, David;Wylie, Sarah A.;Frazier, A. Lindsay;Austin, S. Bryn
通讯作者：
Austin, S. Bryn
影响因子：
2.3
作者：
Arria, Amelia M.;DuPont, Robert L.
通讯作者：
DuPont, Robert L.
影响因子：
4.8
作者：
Li, Dennis H.;Mustanski, Brian
通讯作者：
Mustanski, Brian
影响因子：
4.8
作者：
Lewis, Nathaniel M.
通讯作者：
Lewis, Nathaniel M.
影响因子：
4.8
作者：
Friedman, M. Reuel;Dodge, Brian;Reece, Michael
通讯作者：
Reece, Michael